Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma [Phase 2]
Phase 2 clinical trial update for bortezomib in patients with untreated multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Blood and Marrow Transplant Clinical Research Network [NA]
The Blood and Marrow Transplant Clinical Research Network study has completed, summarizing transplantation approaches across hematologic dis…
-
CLINICAL_TRIALS withdrawal · 2016-02-12Clinical Trial Update: SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma [Phase 2]
A Phase 2 trial of SOM230 LAR in combination with bortezomib and dexamethasone for refractory or relapsed multiple myeloma has been withdraw…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma [Phase 1, Phase 2]
The National Cancer Institute–sponsored Phase 1/2 trial evaluating carfilzomib with stem cell transplantation for plasma cell myeloma was te…
-
EMA approval · 2016-01-29EMA fast-tracks treatment of multiple myeloma for approval in EU
EMA expedites evaluation of a multiple myeloma treatment for potential approval in the European Union.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138 [Phase 1, Phase 2]
This clinical trial update describes CART-138, a CAR-T cell therapy, being studied in Phase 1/2 for chemotherapy-refractory multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 3]
Phase 3 trial comparing oral ixazomib with lenalidomide and dexamethasone versus placebo with lenalidomide and dexamethasone in relapsed/ref…
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating ixazomib in combination with lenalidomide and low-dose dexamethasone in newly diagnosed multiple myeloma has comp…
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function [Phase 1]
Phase 1 study evaluating elotuzumab in combination with lenalidomide and dexamethasone in multiple myeloma across different renal function l…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial evaluated whether adding elotuzumab to bortezomib and dexamethasone improves outcomes in relapsed or refractory multiple mye…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]
This is a Phase 1 clinical trial evaluating the safety and preliminary efficacy of bortezomib in combination with CC-5013 (lenalidomide) in …
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating a regimen of bortezomib, pegylated liposomal doxorubicin (Doxil), and dexamethasone, with or without thali…
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone [Phase 1]
Phase 1 trial update of elotuzumab in combination with lenalidomide and low-dose dexamethasone in Japanese patients with multiple myeloma ha…
-
FDA approval · 2016-01-21FDA Approved: KYPROLIS — Supplemental Application (Onyx Pharmaceuticals, Inc.)
The FDA approved a Supplemental Application for KYPROLIS (carfilzomib) submitted by Onyx Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2016-01-07Clinical Trial Update: The Molecular Characterization of Multiple Myeloma at Relapse
The trial update reports completed efforts to characterize the molecular features of multiple myeloma at relapse, focusing on biomarker and …
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Cancer Stem Cells in Multiple Myeloma
A clinical trial investigating cancer stem cells in multiple myeloma has completed its study.
-
CLINICAL_TRIALS research · 2016-01-05Clinical Trial Update: Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma
This clinical trial update describes an expanded treatment protocol using panobinostat in combination with bortezomib and dexamethasone for …
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma [Phase 1]
This Phase 1 trial update reports safety and dose information for GRN163L in patients with refractory or relapsed multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma [Phase 1]
Phase 1 safety and dose study of GRN163L with Velcade (bortezomib) in patients with refractory or relapsed multiple myeloma has completed. T…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
Study investigating oral ixazomib in combination with lenalidomide and dexamethasone in newly diagnosed multiple myeloma completed with resu…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies [Phase 1]
A Phase 1 clinical trial update evaluating high-dose cytarabine in combination with deoxycytidine for acute myeloid leukemia and other hemat…
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients [Phase 3]
Phase 3 trial comparing carfilzomib-dexamethasone to bortezomib-dexamethasone in relapsed multiple myeloma has completed with posted results…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function [Phase 2]
Phase 2 study assessing safety and pharmacokinetics of carfilzomib in relapsed/refractory multiple myeloma across varying renal function; re…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1, Phase 2]
ClinicalTrials.gov reports a Phase 1b/2 study of carfilzomib in relapsed solid tumors, multiple myeloma, or lymphoma. The study is completed…
-
CLINICAL_TRIALS research · 2015-12-08Clinical Trial Update: Microdose Study of Melphalan, Bortezomib and Dexamethasone [EARLY_Phase 1]
An early-phase clinical trial update evaluating a microdose combination of melphalan, bortezomib, and dexamethasone for multiple myeloma.